Clinical Trials
102 trialsDNAmetCRB
Istituto Ortopedico Rizzoli
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
H. Lee Moffitt Cancer Center and Research Institute
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
St. Jude Children's Research Hospital
OSE
Gustave Roussy, Cancer Campus, Grand Paris
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
St. Jude Children's Research Hospital
IACE-OS
Shanghai 6th People's Hospital
PEMBROSARC
Institut Bergonié
BOOST
University of Minnesota
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
AMLAS
University of Milano Bicocca
PRIMHADRON
Hospices Civils de Lyon
Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
M.D. Anderson Cancer Center
METZOLIMOS
Institut Bergonié
Onco-QoL
Istituto Ortopedico Rizzoli
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Children's National Research Institute
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Emory University
ImmunoSarc
Grupo Espanol de Investigacion en Sarcomas
OAIE
Peking University People's Hospital
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Accuracy of Deep-learning Algorithm for Detection and Risk Stratification of Lung Nodules
Chinese University of Hong Kong
Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.
Children's Cancer Hospital Egypt 57357
ASCR
Washington University School of Medicine
Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance
Peking University People's Hospital
Osteosarcoma
Stanford University
PICaSO-ES
University Health Network, Toronto
Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient
First Affiliated Hospital, Sun Yat-Sen University
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Sarcoma Alliance for Research through Collaboration
AflacST1501
Emory University
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Birmingham Women's and Children's NHS Foundation Trust
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
St. Jude Children's Research Hospital
M6620 (VX-970) in Selected Solid Tumors
Massachusetts General Hospital
NAC to Prevent Cisplatin-induced Hearing Loss
Children's Hospital Los Angeles
ESWT
Krishnadevaraya College of Dental Sciences & Hospital
Cabozantinib With Topotecan-Cyclophosphamide
Dana-Farber Cancer Institute
Drug Sensitivity and Mutation Profiling
Florida International University
Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma
Ruijin Hospital
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Northwestern University
LVPK
BTG International Inc.
CSSG-02
Peking University People's Hospital
The Prognostic Value of Serum Biomarkers in Osteosarcoma
Istituto Ortopedico Rizzoli
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Peking University People's Hospital
SAMHY SARCOME
Institut Claudius Regaud
ReTraSarc
University Medicine Greifswald
Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
The Hospital for Sick Children
ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
Grupo Espanol de Investigacion en Sarcomas
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
M.D. Anderson Cancer Center
Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma
Peking University People's Hospital
Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study
Peking University People's Hospital
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
St. Jude Children's Research Hospital